Results 51 - 60 of 249 : Previous 2 3 4 5 6 7 8 9 10 Next
This Just In: Upgrades and Downgrades
Blair and Needham adopt a BABY.
Quantitative mutual funds have failed in their mission -- at least for now.
This Just In: Upgrades and Downgrades
JMP sticks a fork in Intuitive Surgical and calls it done.
Stock Smackdown: Cramer vs. CAPS
A showdown over who knows stocks better.
Amgen isn't recession-proof either.
When it's at hand, income becomes the focus of your portfolio.
That's what Gilead is.
This Is the Opportunity You've Been Waiting For
This is it.
Biogen grows earnings, but what does that say about the future.
4-Star Stocks Poised to Pop: Celgene
Market-trouncing returns could be written in these four stars.